3D011 / 3DMed - LARVOL DELTA

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=0 | Withdrawn | Sponsor: 3D Medicines (Beijing) Co., Ltd. | N=93 ➔ 0 | Trial completion date: Dec 2023 ➔ Sep 2023 | Recruiting ➔ Withdrawn | Trial primary completion date: Dec 2023 ➔ Sep 2023

Enrollment change • Metastases • Monotherapy • Trial completion date • Trial primary completion date • Trial withdrawal • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Prostate Cancer • Renal Cell Carcinoma • Solid Tumor

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=93 | Recruiting | Sponsor: 3D Medicines (Beijing) Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Monotherapy • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor